A team of Massachusetts General Hospital (MGH) investigators have made the first steps towards development of bioartificial replacement limbs suitable for transplantation. In their report the researchers describe using an experimental approach previously used to build bioartificial organs to engineer rat forelimbs with functioning vascular and muscle tissue. The data findings also provided evidence that the same approach could be applied to the limbs of primates. The study is published in the journal Biomaterials.
The team explain that the composite nature of limbs makes building a functional biological replacement particularly challenging. They go on to add that limbs contain muscles, bone, cartilage, blood vessels, tendons, ligaments and nerves, each of which has to be rebuilt and requires a specific supporting structure called the matrix. The current study shows that the matrix of all of these tissues in their natural relationships to each other can be maintained, that the entire construct can be cultured over prolonged periods of time, and that the vascular system and musculature can be repopulated.
The researchers note that more than 1.5 million individuals in the U.S. have lost a limb, and although prosthetic technology has greatly advanced, the devices still have many limitations in terms of both function and appearance. Over the past two decades a number of patients have received donor hand transplants, and while such procedures can significantly improve quality of life, they also expose recipients to the risks of life-long immunosuppressive therapy. Previous studies show that while the progenitor cells needed to regenerate all of the tissues that make up a limb could be provided by the potential recipient, what has been missing is the matrix or scaffold on which cells could grow into the appropriate tissues.
The current study uses technology developed by team and involves living cells which are stripped from a donor organ with a detergent solution and the remaining matrix repopulated with progenitor cells appropriate to the specific organ. The team have used this decellularization technique to regenerate kidneys, livers, hearts and lungs from animal models, but this is the first reported use to engineer the more complex tissues of a bioartificial limb.
The same decellularization process used in previous whole-organ studies, perfusing a detergent solution through the vascular system, was used to strip all cellular materials from forelimbs removed from deceased rats in the current study. The method used preserved the primary vasculature and nerve matrix. After thorough removal of cellular debris, a process that took a week, what remained was the cell-free matrix that provides structure to all of a limb’s composite tissues. At the same time, populations of muscle and vascular cells were being grown in culture by the team.
The researchers then cultured the forelimb matrix in a bioreactor, within which vascular cells were injected into the limb’s main artery to regenerate veins and arteries. Muscle progenitors were injected directly into the matrix sheaths that define the position of each muscle. After five days in culture, electrical stimulation was applied to the potential limb graft to further promote muscle formation, and after two weeks, the grafts were removed from the bioreactor. Analysis of the bioartificial limbs confirmed the presence of vascular cells along blood vessel walls and muscle cells aligned into appropriate fibers throughout the muscle matrix.
Functional testing of the isolated limbs showed that electrical stimulation of muscle fibers caused them to contract with a strength 80 percent of what would be seen in newborn animals. The vascular systems of bioengineered forelimbs transplanted into recipient animals quickly filled with blood which continued to circulate, and electrical stimulation of muscles within transplanted grafts flexed the wrists and digital joints of the animals’ paws. The research team also successfully decellularized baboon forearms to confirm the feasibility of using this approach on the scale that would be required for human patients.
The team notes that, while regrowing nerves within a limb graft and reintegrating them into a recipient’s nervous system is one of the next challenges that needs to be faced, the experience of patients who have received hand transplants is promising in other studies. They go to add that in clinical limb transplantation, nerves do grow back into the graft, enabling both motion and sensation, and say the have learned that this process is largely guided by the nerve matrix within the graft.
For the future the lab hope to show that the same will apply to bioartificial grafts. Additional next steps will be replicating the current study’s success in muscle regeneration with human cells and expanding that to other tissue types, such as bone, cartilage and connective tissue.
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.